• Expertise
    • Design Development
    • Manufacturing
      • Injection moulding
      • Assembly
      • Packaging
      • Filling
      • Development on request
  • Devices
    • Connected devices
    • Pharmaceutical Devices
  • Who are we
    • Our values
    • Our history
    • Our team
    • Career opportunities
    • Certifications / They trust us
  • Media
    • Press releases
  • News
  • Contact
    • Contact
    • Legal notice
    • Cookies
  • EN
Biocorp
  • Expertise
    • Design Development
    • Manufacturing
      • Injection moulding
      • Assembly
      • Packaging
      • Filling
      • Development on request
  • Devices
    • Connected devices
    • Pharmaceutical Devices
  • Who are we
    • Our values
    • Our history
    • Our team
    • Career opportunities
    • Certifications / They trust us
  • Media
    • Press releases
  • News
  • Contact
    • Contact
    • Legal notice
    • Cookies
  • EN

PR 2023

BIOCORP reports half-year results as of June 30, 2023

230904 PR_BIOCORP_H1 results

Previous

Next

Biocorp is now a Novo Nordisk company

Click here for more information
or send a mail